K12TR004529
Project Grant  
Overview
                Grant Description
              
              
                Ctsa K12 program at the University of Texas Health Science Center at San Antonio - abstract. Since 2008, the UT Health Science Center at San Antonio’s CTSA KL2 mentored career development program has had an exemplary track record of training and mentoring junior faculty. Our program has been recognized nationally for the diversity of its scholars, with 55% women and 33% under-represented persons.
It is also recognized for forming and co-leading a national KL2 PI/directors consortium group, which meets regularly to network, share best practices, and develop innovative programs, such as the virtual CTSA visiting scholars program. In which KL2 scholars throughout the CTSA consortium can visit other CTSA hubs to network with experts in their field and to deliver a nationally streamed CTSA grand rounds.
Our KL2 program has provided 2 years of support for our scholars, with a required third year of support funded by the scholar’s home department. To date, our KL2 program, like others in the CTSA consortium, has focused on translational research – the endeavor to traverse a particular step of the translational process for a particular target or disease. Yet, historically, the process of translation has been notoriously slow.
For the new K12 program, we have the opportunity to add a focus on translational science, the field of investigation focused on understanding the scientific and operational principles underlying each step of the translational process in order to catalyze translation. As such, we will incorporate new training in translational science based on competencies we published for a translational researcher vs. a translational scientist; diversity, equity, inclusion, and accessibility; dissemination and implementation; and leadership.
The curriculum will be co-developed with the University of Utah CTSA and targeted to K12 scholars from both CTSA hubs, T32 trainees, and other members of the translational science workforce. Once developed, the curriculum will be shared with the CTSA consortium. We will continue our rigorous and inclusive scholar selection process.
For their research projects, each K12 scholar will incorporate a component of translational science. Scholars will be mentored by a team of mentors, including a clinician; the primary mentors will undergo evidence-based mentor training, with an emphasis on mentoring under-represented scholars.
With the formalization of our partnerships with UT Austin, UT San Antonio, and Texas Biomedical Research Institute, we will increase the number of CTSA-funded scholars from the current 4 at a time to 5 at a time, plus 3 institutionally funded scholars. We will diversify the leadership of the K12 by adding a female multi-PI from UT Austin and by mentoring an under-represented former scholar to become a K12 program leader.
To continue the highly successful virtual CTSA visiting scholar program once support by the National CTSA Coordinating Center sunsets, we, with K12/KL2 programs at Harvard, the University of North Carolina, and Stanford, will assume management of the program, create innovative features, and evaluate program and scholar experiences.
Together, these K12 program features promise to yield investigators who will become leaders in translational research and the science of translation.
            It is also recognized for forming and co-leading a national KL2 PI/directors consortium group, which meets regularly to network, share best practices, and develop innovative programs, such as the virtual CTSA visiting scholars program. In which KL2 scholars throughout the CTSA consortium can visit other CTSA hubs to network with experts in their field and to deliver a nationally streamed CTSA grand rounds.
Our KL2 program has provided 2 years of support for our scholars, with a required third year of support funded by the scholar’s home department. To date, our KL2 program, like others in the CTSA consortium, has focused on translational research – the endeavor to traverse a particular step of the translational process for a particular target or disease. Yet, historically, the process of translation has been notoriously slow.
For the new K12 program, we have the opportunity to add a focus on translational science, the field of investigation focused on understanding the scientific and operational principles underlying each step of the translational process in order to catalyze translation. As such, we will incorporate new training in translational science based on competencies we published for a translational researcher vs. a translational scientist; diversity, equity, inclusion, and accessibility; dissemination and implementation; and leadership.
The curriculum will be co-developed with the University of Utah CTSA and targeted to K12 scholars from both CTSA hubs, T32 trainees, and other members of the translational science workforce. Once developed, the curriculum will be shared with the CTSA consortium. We will continue our rigorous and inclusive scholar selection process.
For their research projects, each K12 scholar will incorporate a component of translational science. Scholars will be mentored by a team of mentors, including a clinician; the primary mentors will undergo evidence-based mentor training, with an emphasis on mentoring under-represented scholars.
With the formalization of our partnerships with UT Austin, UT San Antonio, and Texas Biomedical Research Institute, we will increase the number of CTSA-funded scholars from the current 4 at a time to 5 at a time, plus 3 institutionally funded scholars. We will diversify the leadership of the K12 by adding a female multi-PI from UT Austin and by mentoring an under-represented former scholar to become a K12 program leader.
To continue the highly successful virtual CTSA visiting scholar program once support by the National CTSA Coordinating Center sunsets, we, with K12/KL2 programs at Harvard, the University of North Carolina, and Stanford, will assume management of the program, create innovative features, and evaluate program and scholar experiences.
Together, these K12 program features promise to yield investigators who will become leaders in translational research and the science of translation.
                Funding Goals
              
              
                NOT APPLICABLE
              
            
                  
                    Grant Program (CFDA)
                  
            
              
              
            
                
                Awarding / Funding Agency
                
              
              
            
                Place of Performance
              
              
                San Antonio,  
                                
                Texas 
                
                
                782293901 
                
                
                
                United States 
            
                Geographic Scope
              
              
                Single Zip Code 
            
                Related Opportunity
              
              
            
                Analysis Notes
              
              
                
                Amendment Since initial award the total obligations have increased 226% from $958,666 to $3,120,974. 
                
              
            
            
            The University Of Texas Health Science Center At San Antonio was awarded
            
             Translational Science Leadership Program UT Health Science Center San Antonio    
            Project Grant K12TR004529
             worth $3,120,974
            from National Center for Advancing Translational Sciences in September 2023 with work to be completed primarily in San Antonio Texas United States.
            The grant
             has a duration of 5 years and 
             was awarded through assistance program 93.350 National Center for Advancing Translational Sciences.
            
            
            The Project Grant was awarded through grant opportunity Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional).
            
          
        Status
          
          
            
            (Ongoing)
            
          
          
        
      Last Modified 8/20/25
Period of Performance
        9/1/23
           
            
            Start Date
          8/31/28
            
            End Date
          Funding Split
        $3.1M
            Federal Obligation
          $0.0
            Non-Federal Obligation
          $3.1M
            Total Obligated
          Activity Timeline
Subgrant Awards
Disclosed subgrants for K12TR004529
Transaction History
Modifications to K12TR004529
Additional Detail
            Award ID FAIN
          
          
            K12TR004529
          
        
            SAI Number
          
          
            K12TR004529-1312953600
          
        
            Award ID URI
          
          
            SAI UNAVAILABLE
          
        
            Awardee Classifications
          
          
            Public/State Controlled Institution Of Higher Education
          
        
            Awarding Office
          
          
            
            75NR00 NIH National Center for Advancing Translational Sciences
            
          
        
            Funding Office
          
          
            
            75NR00 NIH National Center for Advancing Translational Sciences
            
          
        
            Awardee UEI
          
          
            C3KXNLTAAY98
          
        
            Awardee CAGE
          
          
            0NJ12
          
        
            Performance District
          
          
            
            TX-20
            
          
        
            Senators
          
          
            
            John Cornyn 
Ted Cruz
            
          
        Ted Cruz
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage | 
|---|---|---|---|---|
| National Center for Advancing Translational Sciences, National Institutes of Health, Health and Human Services (075-0875) | Health research and training | Grants, subsidies, and contributions (41.0) | $958,666 | 100% | 
Modified: 8/20/25
 
  
           
  